Just a moment, the page is loading...

GSK-111567




Evaluation of the immunogenicity and safety of a commercially available vaccine when co-administered with GlaxoSmithKline Biologicals' HPV vaccine (580299) in healthy female subjects.
Human Papillomavirus Types 16 and 18 Vaccine
111567
NCT00637195 2007-007876-41
Infections, Papillomavirus
Phase 3
May 2013